SB 322 – Hawaii

Status: Inactive / Dead
Year Introduced: 2021
Link: https://www.capitol.hawaii.gov/measure_indiv.aspx?billtype=SB&billnumber=322&year=2022

Requires that if a proposed increase in the wholesale price of certain drugs would result in a 16 per cent or more price increase over a two-year period, the drug manufacturer shall notify various drug insurance providers.

Return to Database Search

© 2018-2019 The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found